LMATLeMaitre Vascular, Inc.
Is the business good?
A genuinely good business: earnings fully cash-backed (1.4×) and margins widening.
Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.
Operating profit is fully backed by cash.
Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is LMAT?
- Cash conversion
- 1.39×
Cash conversion · 1.39× a year ago · operating cash flow covers the operating profit after tax
- Share count, year on year
- +7.2%
Share count, year on year · shareholders own a smaller slice than a year ago
| Year | Operating margin |
|---|---|
| FY2020 | 22% |
| FY2021 | 24% |
| FY2022 | 17% |
| FY2023 | 19% |
| FY2024 | 24% |
| FY2025 | 27% |
Details›
- Free cash flow, trailing twelve months
- $74M
- Net income, trailing twelve months
- $66M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Medical Instruments & Supplies
Ranks #2 of 21 by RyuScore